Bvlgari revisits its most emblematic designs, showing how true icons evolve with time—without losing the essence that defines ...

According to Abbas Kanani, a superintendent pharmacist with Chemist Click, “apple cider vinegar contains polyphenols, an ...

Bengaluru Smart Infrastructure Limited (B-SMILE), a dedicated special-purpose vehicle (SPV) to execute big ticket infrastructure projects in the city, will have an initial financial commitment of ...

While CAR T cell therapy—a personalized form of cancer immunotherapy first successfully developed by Carl June, MD, and his team at Penn—has revolutionized treatment for many blood cancers ...

B cells found to be crucial for long-term vaccine protection, new study shows The new findings could help improve vaccine effectiveness in some immunocompromised patients Date: April 23, 2025 ...

Boehringer Ingelheim has joined the surge of companies entering the B-cell depletion space. But while its peers have largely focused on CAR-Ts and bispecifics, the German drugmaker has paid Cue ...

That trial, the first randomized, double-blind, placebo-controlled study ever conducted in IgG4-RD, confirmed “beyond doubt” that B-cell depletion is an effective treatment strategy for the ...

New study demonstrates how high-affinity B cells 'bank' their best traits instead of rolling the dice and risking deleterious mutations, with implications for better vaccine design. A vaccine's ...

Cemacabtagene ansegedleucel, an allogeneic chimeric antigen receptor (CAR) T-cell therapy, is being investigated in relapsed/refractory large B-cell lymphoma. The investigational allogeneic ...

A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the long-term, drug-free remission from autoimmune diseases observed after treatment ...

Video content above is prompted by the following: Thanks to all of you for this rich and informative discussion. Before we conclude, I’d like to get final thoughts from each of you.

B-PLL is a rare subtype that’s more aggressive than other blood cancers and has a low survival rate. However, ongoing research and clinical trials may offer new treatment options to improve ...